• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉注射免疫球蛋白治疗慢性炎症性脱髓鞘性多发性神经病后时空步态参数的变化

Changes in spatiotemporal gait parameters following intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.

作者信息

Vo Mary L, Chin Russell L, Miranda Caroline, Latov Norman

机构信息

Peripheral Neuropathy Center, Weill Cornell Medical College, 1305 York Avenue, 2nd Floor, New York, New York, 10021, USA.

Department of Neurology, New York Presbyterian Hospital-Weill Cornell Medical College, New York, New York, USA.

出版信息

Muscle Nerve. 2017 Oct;56(4):732-736. doi: 10.1002/mus.25553. Epub 2017 Mar 24.

DOI:10.1002/mus.25553
PMID:28085193
Abstract

INTRODUCTION

Gait impairment is a common presenting symptom in patients with chronic inflammatory demyelinating polyneuropathy (CIDP). However, gait parameters have not previously been evaluated in detail as potential independent outcome measures.

METHODS

We prospectively measured changes in spatiotemporal gait parameters of 20 patients with CIDP at baseline and following treatment with intravenous immunoglobulin (IVIG), using GAITRite® a computerized walkway system with embedded sensors.

RESULTS

Overall, study patients showed significant improvements in gait velocity, cadence, stride length, double support time, stance phase, and swing phase following IVIG treatment. Mean changes in velocity, stance phase, and swing phase, exhibited the greatest statistical significance among the subgroup that exhibited clinically meaningful improvement in Inflammatory Neuropathy Cause and Treatment disability score, Medical Research Council sum score, and grip strength.

CONCLUSIONS

Assessment of gait parameters, in particular velocity, step phase and swing phase, is a potentially sensitive outcome measure for evaluating treatment response in CIDP. Muscle Nerve 56: 732-736, 2017.

摘要

引言

步态障碍是慢性炎症性脱髓鞘性多发性神经病(CIDP)患者常见的症状表现。然而,此前尚未将步态参数作为潜在的独立疗效指标进行详细评估。

方法

我们前瞻性地测量了20例CIDP患者在基线时以及接受静脉注射免疫球蛋白(IVIG)治疗后的时空步态参数变化,使用的是带有嵌入式传感器的GAITRite®计算机化步道系统。

结果

总体而言,研究患者在接受IVIG治疗后,步态速度、步频、步幅、双支撑时间、站立期和摆动期均有显著改善。在炎症性神经病病因与治疗残疾评分、医学研究委员会总分和握力方面表现出具有临床意义改善的亚组中,速度、站立期和摆动期的平均变化具有最大的统计学意义。

结论

评估步态参数,尤其是速度、步期和摆动期,是评估CIDP治疗反应的潜在敏感疗效指标。《肌肉与神经》56: 732 - 736, 2017年。

相似文献

1
Changes in spatiotemporal gait parameters following intravenous immunoglobulin treatment for chronic inflammatory demyelinating polyneuropathy.静脉注射免疫球蛋白治疗慢性炎症性脱髓鞘性多发性神经病后时空步态参数的变化
Muscle Nerve. 2017 Oct;56(4):732-736. doi: 10.1002/mus.25553. Epub 2017 Mar 24.
2
Acute motor response following a single IVIG treatment course in chronic inflammatory demyelinating polyneuropathy.慢性炎症性脱髓鞘性多发性神经病单次静脉注射免疫球蛋白治疗后的急性运动反应
Muscle Nerve. 2009 Apr;39(4):439-47. doi: 10.1002/mus.21305.
3
Long-term neurophysiological and clinical response in patients with chronic inflammatory demyelinating polyradiculoneuropathy treated with subcutaneous immunoglobulin.慢性炎症性脱髓鞘性多发性神经根神经病患者接受皮下免疫球蛋白治疗的长期神经生理学和临床反应。
Clin Neurophysiol. 2018 May;129(5):967-973. doi: 10.1016/j.clinph.2018.01.070. Epub 2018 Feb 19.
4
Subcutaneous immunoglobulin for maintenance treatment in chronic inflammatory demyelinating polyneuropathy (The PATH Study): study protocol for a randomized controlled trial.皮下注射免疫球蛋白用于慢性炎性脱髓鞘性多发性神经病的维持治疗(PATH研究):一项随机对照试验的研究方案
Trials. 2016 Jul 25;17(1):345. doi: 10.1186/s13063-016-1466-2.
5
Motor unit number index (MUNIX) in chronic inflammatory demyelinating polyneuropathy: A potential role in monitoring response to intravenous immunoglobulins.慢性炎症性脱髓鞘性多发性神经病中的运动单位数目指数(MUNIX):在监测静脉注射免疫球蛋白反应中的潜在作用。
Clin Neurophysiol. 2019 Oct;130(10):1743-1749. doi: 10.1016/j.clinph.2019.06.231. Epub 2019 Jul 19.
6
Optimization of intravenous immunoglobulin in chronic inflammatory demyelinating polyneuropathy evaluated by grip strength measurement.通过握力测量评估慢性炎症性脱髓鞘性多发性神经病的静脉注射免疫球蛋白的优化。
Eur Neurol. 2013;70(1-2):65-9. doi: 10.1159/000350287. Epub 2013 Jun 19.
7
CIDP variants in diabetes: measuring treatment response with a small nerve fiber test.糖尿病中的慢性炎症性脱髓鞘性多发性神经病(CIDP)变体:通过小神经纤维检测评估治疗反应
J Diabetes Complications. 2015 Mar;29(2):313-7. doi: 10.1016/j.jdiacomp.2014.10.012. Epub 2014 Nov 6.
8
Electrophysiologic correlations with clinical outcomes in CIDP.CIDP 患者的电生理相关性与临床结局。
Muscle Nerve. 2010 Oct;42(4):492-7. doi: 10.1002/mus.21733.
9
Chronic Inflammatory Demyelinating Polyneuropathy: Time to Maximal Recovery in Patients Receiving Intravenous Immunoglobulin Therapy.慢性炎症性脱髓鞘性多发性神经病:接受静脉注射免疫球蛋白治疗患者达到最大恢复的时间
Can J Neurol Sci. 2020 Jul;47(4):531-537. doi: 10.1017/cjn.2020.69. Epub 2020 Apr 13.
10
Clinical and economic comparison of an individualised immunoglobulin protocol vs. standard dosing for chronic inflammatory demyelinating polyneuropathy.个体化免疫球蛋白方案与慢性炎症性脱髓鞘性多发性神经病标准剂量治疗的临床和经济比较。
J Neurol. 2019 Feb;266(2):461-467. doi: 10.1007/s00415-018-9157-4. Epub 2018 Dec 17.

引用本文的文献

1
Validity and Responsiveness of Balance Measurements Using Posturography in Patients With Immune-Mediated Neuropathies.姿势描记法对免疫介导性神经病患者平衡测量的有效性和反应性
J Peripher Nerv Syst. 2025 Jun;30(2):e70031. doi: 10.1111/jns.70031.
2
Wearable Health Technology to Quantify the Functional Impact of Peripheral Neuropathy on Mobility in Parkinson's Disease: A Systematic Review.可穿戴健康技术量化帕金森病周围神经病变对移动功能的影响:系统评价。
Sensors (Basel). 2020 Nov 19;20(22):6627. doi: 10.3390/s20226627.
3
Risk of osteoporosis in patients with chronic inflammatory neuropathy- a population-based cohort study.
慢性炎症性神经病患者的骨质疏松风险——基于人群的队列研究。
Sci Rep. 2019 Jun 24;9(1):9131. doi: 10.1038/s41598-019-45591-4.